These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20214307)

  • 1. [Side effects of therapy and management].
    Ciocca M; Daruich J; Fernández N
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S59-62. PubMed ID: 20214307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
    MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
    [No Abstract]   [Full Text] [Related]  

  • 3. Hematologic side effects of PEG interferon and ribavirin. Management with growth factors.
    Keeffe EB; Kowdley KV
    J Clin Gastroenterol; 2005 Jan; 39(1 Suppl):S1-2. PubMed ID: 15597022
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
    Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
    [No Abstract]   [Full Text] [Related]  

  • 5. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
    Demirturk N; Aykin N; Demirdal T; Cevik F
    Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
    [No Abstract]   [Full Text] [Related]  

  • 6. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
    Ku JY; Sharma A
    Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Shafa S; Borum ML; Igiehon E
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):122-3. PubMed ID: 19959941
    [No Abstract]   [Full Text] [Related]  

  • 8. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon therapy for hepatitis B and C].
    Iino S
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. Renal impairment addressed in labeling.
    AIDS Alert; 2011 Nov; 26(11):131. PubMed ID: 22164522
    [No Abstract]   [Full Text] [Related]  

  • 11. Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
    Onyike CU; Bonner JO; Lyketsos CG; Treisman GJ
    Am J Psychiatry; 2004 Mar; 161(3):429-35. PubMed ID: 14992966
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
    Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
    Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
    Sprenger R; Sagmeister M; Offner F
    Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-induced thyroid dysfunction--not always transient.
    Wong VW; Cheng AY; Chan HL
    J Gastroenterol Hepatol; 2009 Jun; 24(6):938-40. PubMed ID: 19638076
    [No Abstract]   [Full Text] [Related]  

  • 16. Peginterferon and ribavirin for hepatitis C.
    Ben Salem C; Hmouda H; Bouraoui K
    N Engl J Med; 2007 Mar; 356(12):1270; author reply 1271. PubMed ID: 17380578
    [No Abstract]   [Full Text] [Related]  

  • 17. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
    Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
    J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Medicines for liver diseases; interferon preparations and anti-hepatitis virus agents].
    Iwasaki Y; Ikeda F; Yamamoto K
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():272-8. PubMed ID: 23156520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C infection. Overweight virus carriers are more difficult to cure].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combination therapy for chronic viral hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.